Dr Anne Armstrong and Prof Nigel Bundred discuss genomic profiling of breast cancer - European Medical Journal

Dr Anne Armstrong and Prof Nigel Bundred discuss genomic profiling of breast cancer

Oncology

Anne Armstrong, MRCP, PhD, MB ChB, BSc(Hons), of The Christie Hospital, Manchester, UK, and Nigel Bundred, MD, FRCS, of The University of Manchester, UK, discuss genomic profiling for patients with breast cancer and the Oncotype DX® Breast Cancer Assay.

This content is supported by Genomic Health, Inc.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given